Karen Krasney, J.D.

Karen Krasney, J.D.

Executive Vice President & General CounselatCapricor Therapeutics· In proxies 2022–2025

Pay in FY2025+46% from the year before · Capricor Therapeutics stock +109.1% the same year

Karen Krasney, J.D. was paid $1.3M in FY2025 (Dec), up 46%. Capricor Therapeutics stock rose 109.1% that year.

Pay$100 in the stock at the end of FY21 → $985
Pay is from the Summary Compensation Table of each Capricor Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Capricor TherapeuticsPublic company · 4 yr
    • Executive Vice President & General Counsel2022 – Present · 4 yrStock in role +93%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?